Anthrax (Gastrointestinal)MANAGEMENT

INFECTIOUS DISEASE PRESENTATIONS · 12 SECTIONS

⚲

555 items

☷ Legend

01Approach to the Critical Patient/attcp60

Immediate priorities

›Airway and breathing threats

›Oropharyngeal variant airway compromise

›Massive cervical edema and neck swelling

›Pharyngeal pseudomembrane obstructing airway

›Mediastinal involvement

›Mediastinal widening can occur with GI anthrax

›Pleural effusion causing respiratory compromise

›If progressive pharyngeal edema, early definitive airway control

›Anticipate difficult airway

›Anesthesia and surgical airway backup at bedside

›Circulation and toxemia threats

›Hemorrhagic shock physiology

›Massive GI bleeding source

›SBP < 90 mmHg

›Distributive shock from toxemia

›MAP < 65 mmHg

›Lactate >= 2 mmol/l

›If shock, aggressive crystalloid resuscitation and early vasopressors

›Norepinephrine first line

›Blood products for hemorrhage

›Time-critical antitoxin and antibiotics

›Empiric therapy before confirmation

›Do not delay for laboratory confirmation

›First antibiotic dose within 1 hour of suspicion

›Antitoxin coordination

›Raxibacumab or obiltoxaximab via CDC

›Anthrax immune globulin alternative

02History/hx55

Presentation pattern

›Lower GI syndrome

›Initial prodrome

›Nausea and vomiting

›Malaise and anorexia

›Progressive phase

›Severe abdominal pain

›Bloody diarrhea

›Late phase

›Abdominal distention from ascites

›Hematemesis or coffee-ground emesis

›Oropharyngeal variant

›Local symptoms

›Sore throat and dysphagia

›Neck swelling

›Constitutional symptoms

›Fever

›Regional lymphadenopathy

Timing and exposure

›Incubation and tempo

›Incubation period 1-7 days

›Median onset 3 days after ingestion

›Rapid systemic progression over days

›Two-phase course

›Early GI symptoms

›Acute abdomen presentation

›Exposure history

›Dietary exposure

03Physical Exam/exam41

Vitals and general

›Stability snapshot

›Temperature

›Fever common

›Hypothermia as severe sepsis marker

›Hemodynamics

›Tachycardia

›SBP < 90 mmHg as shock marker

›General appearance

›Toxic appearance

›Altered mental status

Abdominal exam

›Abdominal findings

›Tenderness pattern

›Diffuse tenderness

›Rebound and guarding with peritonitis

›Distention and ascites

›Shifting dullness

›Fluid wave

›Perforation signs

›Rigid abdomen

›Absent bowel sounds

Oropharyngeal exam

›Oropharyngeal variant findings

›Mucosal lesions

›Oral or esophageal ulcers

›Overlying pseudomembrane

›Neck findings

04Differential Diagnosis/ddx41

Life threats and cannot-miss

›Surgical and ischemic emergencies

›Intestinal perforation

›Free air on imaging

›Peritonitis

›Mesenteric ischemia

›Pain out of proportion

›Lactic acidosis

›Toxic megacolon

›Colonic dilatation

›Systemic toxicity

›Severe infectious mimics

›Sepsis from other bacteria

›ICD-10 A41.9 association

›Source identification

›Anthrax meningitis

›Up to 77% of systemic cases

›Hemorrhagic CSF

Common GI mimics

›Infectious enteritis

›Acute gastroenteritis

›Viral or bacterial

›Self-limited course

›Bacterial dysentery

›Shigella or Campylobacter

›Bloody diarrhea overlap

›Inflammatory and ulcer disease

›Inflammatory bowel disease flare

05Laboratory Tests/lt52

Microbiologic studies

›Blood cultures

›High diagnostic yield

›B. anthracis grows rapidly

›Obtain before antibiotics when feasible

›Gram stain

›Large gram-positive bacilli

›Boxcar-shaped chains

›Confirmatory testing

›PCR at reference laboratory

›State health department access

›Laboratory Response Network

›Immunohistochemistry

›Tissue specimen staining

›Serology limited and late

Hematologic and metabolic

›Complete blood count

›White cell line

›Leukocytosis with left shift

›Leukopenia as severe sepsis marker

›Red cells and platelets

›Anemia from GI bleeding

›Thrombocytopenia in severe cases

›Metabolic and organ panels

›Comprehensive metabolic panel

›Hemoconcentration from fluid loss

›Renal function for antibiotic dosing

›Liver function tests

06Diagnostic Tests/dt69

Scoring Systems

›Sepsis stratification tools

›qSOFA

›RR >= 22 per minute

›SBP <= 100 mmHg

›Altered mental status

›SOFA score

›Organ dysfunction quantification

›ICU prognostication

›SIRS criteria

›Temperature and heart rate thresholds

›Low specificity adjunct

›Limitations

›No anthrax-specific score

›Generic sepsis tools applied

›Clinical trajectory supersedes single score

›Evidence note

›CDC 2023 emphasizes early empiric treatment over scoring

›Exposure history drives suspicion

MRI

›MRI brain

›Meningitis evaluation

›Hemorrhagic meningoencephalitis pattern

›Subarachnoid and parenchymal hemorrhage

›Indications

›New neurologic deficit

›Altered mental status with sepsis

›Contraindications

07Disposition/dispo45

Level of care

›Admission indications

›All suspected GI anthrax

›Need for IV antibiotics

›Close monitoring requirement

›Systemic illness

›Hemodynamic instability

›Evidence of toxemia

›ICU indications

›Shock and organ failure

›Vasopressor requirement

›Multi-organ dysfunction

›Airway and neurologic threats

›Oropharyngeal airway compromise

›Suspected meningitis

Consultation and transfer

›Specialist consultation

›Infectious disease

›Mandatory for all cases

›Antimicrobial and antitoxin guidance

›Surgery

›Acute abdomen or perforation

›Operative source control

›Critical care

›Severe systemic disease

›Ventilatory or vasopressor needs

›Transfer considerations

›Capability matching

08Treatment/t71

Initial stabilization

›Resuscitation

›Fluid therapy

›Balanced crystalloid for shock

›Reassess after each bolus

›Vasopressor support

›Norepinephrine first line

›Titrate to MAP >= 65 mmHg

›Hemorrhage management

›Packed red cells for significant bleeding

›Correct coagulopathy

›Airway protection

›Oropharyngeal edema

›Early intubation for progressive swelling

›Surgical airway backup

›NPO and decompression

›NPO with acute abdomen

›Nasogastric decompression as needed

Antimicrobial therapy

›Systemic disease triple regimen

›Bactericidal fluoroquinolone

›Ciprofloxacin 400 mg IV every 8-12 hours

›Levofloxacin 750 mg IV daily alternative

›Protein synthesis inhibitor for antitoxin effect

›Clindamycin 900 mg IV every 8 hours

›Linezolid 600 mg IV every 12 hours alternative

›CNS-penetrating beta-lactam if meningitis not excluded

›Meropenem 2 g IV every 8 hours

09Special Populations/sp30

Pregnancy

›Pregnancy considerations

›Maternal severity

›Higher risk of severe disease

›Aggressive treatment warranted

›Antibiotic selection

›Ciprofloxacin preferred when indicated

›Avoid prolonged doxycycline when alternatives exist

›Antitoxin and supportive care

›Antitoxin given for systemic disease

›Fetal monitoring when viable gestation

Geriatric

›Older adult features

›Atypical presentation

›Blunted fever response

›Delirium as early sign

›Higher mortality

›Reduced physiologic reserve

›Earlier ICU consideration

›Medication adjustment

›Renal dosing of fluoroquinolones

›QT prolongation monitoring

Pediatrics

›Pediatric differences

›Weight-based antibiotics

›Ciprofloxacin 10-15 mg/kg IV every 8-12 hours

›Clindamycin 10-13 mg/kg IV every 8 hours

›Meningitis-dose beta-lactam

10Background/b56

Epidemiology

›Frequency and burden

›Rarity

›Rare form of anthrax

›Follows ingestion of contaminated meat

›Mortality

›25-60% mortality if untreated

›Reduced with early aggressive therapy

›Geographic distribution

›Endemic regions

›Sub-Saharan Africa and central Asia

›Southern and eastern Europe

›Sporadic regions

›Southwestern United States wildlife cases

›Linked to agricultural exposure

Pathophysiology

›Organism and toxins

›Bacillus anthracis

›Spore-forming gram-positive bacillus

›Spores germinate in macrophages

›Toxin components

›Protective antigen mediates cell entry

›Lethal factor and edema factor drive injury

›Disease mechanism

›Mucosal invasion

›Ulceration of GI tract

›Spread to mesenteric lymph nodes

›Systemic toxemia

11Patient Discharge Instructions/pdi18

copy discharge instructions

›Gastrointestinal anthrax home care

›Take all antibiotics exactly as prescribed until finished

›Complete the full course even if feeling better

›Finish 60 days of antibiotics if exposure was intentional

›Keep all follow-up appointments

›Warning signs to return to ER

›Worsening or spreading abdominal pain

›Swelling or hardness of the belly

›Vomiting blood or passing bloody stools

›Fever that returns or will not go away

›Severe headache, confusion, or stiff neck

›Trouble breathing or swallowing

›Lightheadedness, fainting, or very little urine

›Prevention and reporting

›Avoid undercooked meat especially from herbivores

›Tell household members to watch for similar symptoms

›Understand this is a reportable disease

›Follow public health guidance for contacts

12References/r17

Guidelines and key sources

›Guideline sources

›CDC Guidelines for the Prevention and Treatment of Anthrax 2023

›Bower WA et al MMWR Recommendations and Reports

›Treatment and postexposure prophylaxis framework

›Anthrax as a Biological Weapon updated recommendations

›Inglesby TV et al JAMA 2002

›Working group consensus management

›Evidence summaries

›Clinical management of bioterrorism-related conditions

›Adalja AA et al NEJM 2015

›Systemic antibiotic therapy principles

›Anthrax infection comprehensive review

›Sweeney DA et al AJRCCM 2011

›Toxin-mediated pathophysiology

›Coding standards

›ICD-10 A22.2 gastrointestinal anthrax

›SNOMED CT gastrointestinal anthrax disorder concept

Learn More: Anthrax (Gastrointestinal)→

Comprehensive Clinical Review

Structured, evidence-informed, long-form analysis for deeper understanding.

Evidence & Review

Reviewed by SymptomDx Medical Team · Last reviewed August 18, 2026

SymptomDx is an educational tool for medical professionals. It does not replace clinical judgment. Verify all clinical data and drug dosages with authoritative sources.